Cowen & Company Initiates Ophthotech With Outperform

Cowen & Company initiated coverage on Ophthotech Corp OPHT with a Outperform rating. The target price for Ophthotech is set to $80. Ophthotech shares have gained 24.98 percent over the past 52 weeks, while the S&P 500 index has surged 5.35 percent in the same period. Ophthotech shares climbed 1.08 percent to close at $52.39 yesterday.